Post-treatment MRI aspects of photodynamic therapy for prostate cancer

Por Kulik, M., Nedelcu, C., Martin, F., Lebdai, S., Rousselet, M. C., Azzouzi, A. R., Aubé, C.
Publicado no Insights Imaging (2014)

Clinical relevance of genetic instability in prostatic cells obtained by prostatic massage in early prostate cancer

Por Thuret, R, Chantrel-Groussard, K, Azzouzi, A-R, Villette, J-M, Guimard, S, Teillac, P, Berthon, P, Houlgatte, A, Latil, A, Cussenot, O
Publicado em 2005

TOOKAD(®) Soluble focal therapy: pooled analysis of three phase II studies assessing the minimally invasive ablation of localized prostate cancer

Por Azzouzi, A. R., Barret, E., Bennet, J., Moore, C., Taneja, S., Muir, G., Villers, A., Coleman, J., Allen, C., Scherz, A., Emberton, M.
Publicado no World J Urol (2015)

S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors

Por Rehman, I, Cross, S S, Azzouzi, A-R, Catto, J W F, Deloulme, J C, Larre, S, Champigneuille, J, Fromont, G, Cussenot, O, Hamdy, F C
Publicado em 2004

Standardization of definitions in focal therapy of prostate cancer: report from a Delphi consensus project

Por Postema, A. W., De Reijke, T. M., Ukimura, O., Van den Bos, W., Azzouzi, A. R., Barret, E., Baumunk, D., Blana, A., Bossi, A., Brausi, M., Coleman, J. A., Crouzet, S., Dominguez-Escrig, J., Eggener, S., Ganzer, R., Ghai, S., Gill, I. S., Gupta, R. T., Henkel, T. O., Hohenfellner, M., Jones, J. S., Kahmann, F., Kastner, C., Köhrmann, K. U., Kovacs, G., Miano, R., van Moorselaar, R. J., Mottet, N., Osorio, L., Pieters, B. R., Polascik, T. J., Rastinehad, A. R., Salomon, G., Sanchez-Salas, R., Schostak, M., Sentker, L., Tay, K. J., Varkarakis, I. M., Villers, A., Walz, J., De la Rosette, J. J.
Publicado no World J Urol (2016)